Xc. Wu et al., Relationship between erythropoietin and nitric oxide in the contraction ofrat renal arcuate arteries and human umbilical vein endothelial cells, CLIN SCI, 97(4), 1999, pp. 413-419
We have investigated the effects of recombinant human erythropoietin (EPO)
on the responses of rat renal arcuate arteries to dopamine, noradrenaline a
nd acetylcholine and on the release of NO from human umbilical vein endothe
lial cells (HUVEC) in culture. Noradrenaline induced a concentration-depend
ent constriction and acetylcholine a concentration-dependent relaxation of
the vessels. The effects of dopamine were concentration-dependent, leading
to relaxation of the vessels at low concentrations and contraction of the v
essels at high concentrations. N-G-Nitro-L-arginine methyl ester (L-NAME; 0
.1 mM) did not change the vasoconstrictor responses to noradrenaline and do
pamine, but inhibited the acetylcholine- and dopamine-induced vasorelaxatio
n. Neither 0.1 nor 20 units . ml(-1) EPO affected noradrenaline-induced con
striction, or dopamine- or acetylcholine-induced relaxation, of the vessels
. EPO at 20 units . ml(-1) attenuated dopamine-induced constriction of the
vessels. Th is effect was blunted by application of L-NAME, suggesting that
EPO may stimulate dopamine-mediated NO release from these vessels. EPO sti
mulated NO release from the resting HUVEC in a concentration- and time-depe
ndent manner, an effect that was inhibited by the presence of N-G-nitro-L-a
rginine, These data suggest that, in vitro, EPO is able to stimulate NO rel
ease from rat renal arcuate arteries and HUVEC in culture. Whether these ac
ute short-term actions can be related to the longer-term actions of EPO rem
ains to be resolved.